Medical Devices & Sensors

The medical device frontier is increasingly defined by miniaturized, AI-enabled, and continuously sensing platforms. GSBG 2027 will examine brain-computer interfaces from Neuralink (N1 implant clinical experience), Synchron (Stentrode), and Paradromics, alongside Precision Neuroscience's thin-film cortical arrays. The track will cover continuous glucose monitoring evolution (Dexcom G7, Abbott Libre 3) and its expansion into non-diabetic populations, multi-analyte wearables for stress and metabolic monitoring, ingestible diagnostics, and CRISPR-based point-of-care platforms (SHERLOCK, DETECTR). Implantable bioelectronic medicine — vagus nerve stimulation, closed-loop neuromodulation — will round out the program.